Process for the preparation of dipeptidylpeptidase inhibitors
Provided is a process for the preparation of linagliptin of Formula I, comprising deprotecting a compound of Formula II wherein R 1 and R 2 together with the nitrogen to which they are attached form a phthalimido group, wherein the aromatic ring of the phthalimido group is substituted with one or more R 3 substituents selected from the group consisting of halogen, alkyi, nitro and amino; or R 1 is H and R 2 is selected from the group consisting of trialkylsilyl, 2-trialkylsilylethoxycarbamates, acetyl, trihaloacetyl, 9-fluorenylmethoxycarbonyl, trityl, alkylsulfonyl, arylsulfonyl, diphenylphosphine and sulfonylethoxycarbonyl.
1. A process for preparing pure linagliptin comprising
(a) converting the linagliptin, a compound of Formula I, into linagliptin dibenzoyl-D-tartaric acid salt;
(b) treating, the linagliptin dibenzoyl-D-tartaric acid salt with a suitable base to form linagliptin, a compound of Formula I; and
(c) isolating the pure linagliptin with a chiral purity of atleast 99.95% as determined by HPLC.
2. The process according to claim 1 , further comprising prior to step (a):
deprotecting a compound of Formula IIA
wherein R 3 is independently selected from the group consisting of halogen, alkyl, nitro and amino to obtain linagliptin, a compound of Formula I.
3. The process according to claim 2 , wherein the step of deprotection is carried out using a reagent selected from the group consisting of a hydrazine, hydrazine hydrate and amine.
4. The process according to claim 2 , wherein the step (a) is carried out using dibhenzoyl-D-tartaric acid.
5. The process according to claim 2 , wherein the compound of Formula IIA is prepared by a process comprising reacting a compound of Formula III, wherein X is a halogen, with a compound of Formula IVA; wherein R 3 is as defined above.
6. The process according to claim 5 , wherein the reaction of the compound of Formula III with the compound of Formula IVA is carried, out in presence of a base.
7. The process according to claim 5 , wherein the compound of Formula IVA is prepared by a process comprising reacting R-(3)-aminopiperidine with substituted phthalic anhydride wherein the aromatic ring of the phthalic anhydride is substituted with one substituents selected from the group consisting of halogen, alkyl, nitro and amino.
8. The process according to claim 7 , for the preparation of a compound of Formula IVA1,
comprising reacting R-(3)-aminopiperidine with 4-methylphthalic anhydride.